Related Experiment Video
Updated: Mar 26, 2026
12:04
Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells
Published on: March 10, 2023
5.1K
Current Role of Genetics in Hematologic Malignancies.
Gaurav Prakash1, Anupriya Kaur2, Pankaj Malhotra1
1Clinical Hematology and BMT Division, Department of Internal Medicine, PGIMER, Chandigarh, India.
Summary
Genetic technologies are revolutionizing hematologic malignancy care, improving diagnosis, treatment selection, and response evaluation. Understanding basic genetics is crucial for hemato-oncology practitioners to apply these advancements in patient care.
Area of Science:
- Hematology
- Oncology
- Genetics
- Molecular Biology
Background:
- Genetic technology advancements significantly impact hematologic malignancy management.
- Genetics is integral to diagnosing and prognosing hematologic neoplasms.
- Genetic testing guides specific treatments and evaluates response depth.
Purpose of the Study:
- To highlight the critical role of genetics in modern hemato-oncology.
- To emphasize the need for practitioners to understand genetic concepts.
- To bridge the gap between molecular research and clinical patient care.
Main Methods:
- Review of current genetic technologies in hematologic malignancies.
- Analysis of the impact of genetic testing on diagnosis and prognosis.
- Discussion of the application of genetic data in treatment decisions and response monitoring.
Main Results:
- Genetic testing is increasingly utilized for personalized treatment strategies.
- Genetics provides essential prognostic information for hematologic neoplasms.
- Rapid advancements necessitate continuous learning for hemato-oncology professionals.
Conclusions:
- A strong foundation in genetics is essential for hemato-oncology practitioners.
- Translating molecular research into clinical practice improves patient outcomes.
- The integration of genetic insights is transforming the management of blood cancers.
Related Concept Videos
01:28Role of Hematopoietic Growth Factors
4.3K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
4.3K
01:28Human Genetics
1.9K
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
1.9K
01:01Regulation of Hematopoietic Stem Cells
4.4K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.4K
01:21Lineage Commitment
4.6K
Commitment is the process whereby stem cells:
4.6K
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
67
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
67
01:21Hematopoiesis
9.7K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
9.7K